University of Missouri – Columbia (MU)
My research investigates how dysregulated cholesterol metabolism contributes to cancer initiation, progression, and immune evasion. By studying both tumor-intrinsic and microenvironmental roles of cholesterol and its derivatives, I aim to identify novel metabolic vulnerabilities that can be targeted for therapy. This work bridges cancer biology with translational strategies, with the goal of developing cholesterol-targeted interventions to improve cancer treatment outcomes.